WGRX · NASDAQ · Medical - Distribution

Wellgistics Health (WGRX)

Connects drug manufacturers, pharmacies, and patients through wholesale distribution and prescription hub services.

$3.52
At close0.00 (0.00%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue03481016−161183222
Cost of revenue0327915−1510731222
Gross profit03111−1110−1000
113244−232632367
18222131531467
Selling & marketing000000001010
General & administrative18222131530457
Other expenses05021−2111−200
Operating income−1−10−1−2−31−31−6−32−13−6−7
0−10000−1−1−3−15−2−11
Interest expense0201001111−2−2
Other non-operating income000001001000
Income before tax−1−12−2−2−30−32−7−34−28−8−18
Net income from continuing operations−1−12−2−2−30−32−7−34−28−8−18
Net income−1−12−2−2−30−32−7−34−28−8−18
EPS, basic−$0.87−$12.60−$1.82−$0.56−$1.80−$4.17−$31.00−$5.50−$23.00−$13.50−$3.70−$7.13
EPS, diluted−$0.87−$12.60−$1.82−$0.56−$1.80−$4.17−$31.00−$5.50−$23.00−$13.50−$3.70−$7.13
Weighted average shares, basic1113
Weighted average shares, diluted1113
EBITDA−1−5−10−21−31−5−32−12−6−7
Depreciation & amortization050211111100
EBIT−1−10−1−2−30−31−5−33−13−60